Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika ; volume:10 ; number:1 ; day:26 ; month:2 ; year:2019 ; pages:1-13 ; date:12.2019
Nature Communications ; 10, Heft 1 (26.2.2019), 1-13, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Andrade, Paulina
Gimblet-Ochieng, Ciara
Modirian, Faraz
Collins, Matthew
Cárdenas, Maritza
Katzelnick, Leah C.
Montoya, Magelda
Michlmayr, Daniela
Kuan, Guillermina
Balmaseda, Angel
Coloma, Josefina
Silva, Aravinda M. de
Harris, Eva
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-019-08845-3
- URN
-
urn:nbn:de:101:1-2019032015414393371352
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Andrade, Paulina
- Gimblet-Ochieng, Ciara
- Modirian, Faraz
- Collins, Matthew
- Cárdenas, Maritza
- Katzelnick, Leah C.
- Montoya, Magelda
- Michlmayr, Daniela
- Kuan, Guillermina
- Balmaseda, Angel
- Coloma, Josefina
- Silva, Aravinda M. de
- Harris, Eva
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evidence of pre-existing active Zika virus circulation in Sudan prior to 2012
Pre-existing adaptive immunity to the RNA-editing enzyme Cas13d in humans
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
Evasion of Pre-Existing Immunity to Cas9: a Prerequisite for Successful Genome Editing In Vivo?
Impact of pre-existing MSP142-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine
Liver gene therapy by lentiviral vectors reverses anti‐factor IX pre‐existing immunity in haemophilic mice
Chikungunya, Dengue, and Zika in Immunocompromised Hosts
Myotoxicity of telbivudine in pre-existing muscle damage
LY6D marks pre-existing resistant basosquamous tumor subpopulations
Theoretically optimal bracing for pre-existing building frames
High frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central Brazil
Evidence of pre-existing active Zika virus circulation in Sudan prior to 2012
Pre-existing adaptive immunity to the RNA-editing enzyme Cas13d in humans
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
Evasion of Pre-Existing Immunity to Cas9: a Prerequisite for Successful Genome Editing In Vivo?
Impact of pre-existing MSP142-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine
Liver gene therapy by lentiviral vectors reverses anti‐factor IX pre‐existing immunity in haemophilic mice
Chikungunya, Dengue, and Zika in Immunocompromised Hosts
Myotoxicity of telbivudine in pre-existing muscle damage
LY6D marks pre-existing resistant basosquamous tumor subpopulations
Theoretically optimal bracing for pre-existing building frames
High frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central Brazil
Evidence of pre-existing active Zika virus circulation in Sudan prior to 2012
Pre-existing adaptive immunity to the RNA-editing enzyme Cas13d in humans
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
Evasion of Pre-Existing Immunity to Cas9: a Prerequisite for Successful Genome Editing In Vivo?
Impact of pre-existing MSP142-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine
Liver gene therapy by lentiviral vectors reverses anti‐factor IX pre‐existing immunity in haemophilic mice
Chikungunya, Dengue, and Zika in Immunocompromised Hosts
Myotoxicity of telbivudine in pre-existing muscle damage
LY6D marks pre-existing resistant basosquamous tumor subpopulations
Theoretically optimal bracing for pre-existing building frames